Sunshine Biopharma Inc. (SBFMW) stock
SBFMWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFM
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.03+0.00 (+2.00%)
Close on Oct 30, 2026Market cap $11.36MP/E –Yield –
Sunshine Biopharma total assets
Total assets on the balance sheet at the end of each period.
Sunshine Biopharma's total assets was $33.63M at Jun 30, 2026. For fiscal 2025 it was $30.08M, down 1.6% from the year before. Over ten years it grew 46.2% a year on average. The highest annual figure on record is $30.56M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.08M | -1.6% |
| FY2024 | Dec 31, 2024 | $30.56M | +11.8% |
| FY2023 | Dec 31, 2023 | $27.35M | -6.5% |
| FY2022 | Dec 31, 2022 | $29.24M | +1227.5% |
| FY2021 | Dec 31, 2021 | $2.20M | +110.7% |
| FY2020 | Dec 31, 2020 | $1.05M | +965.3% |
| FY2019 | Dec 31, 2019 | $98.14K | -91.4% |
| FY2018 | Dec 31, 2018 | $1.15M | +345.3% |
| FY2017 | Dec 31, 2017 | $257.49K | +299.8% |
| FY2016 | Dec 31, 2016 | $64.40K | -90.4% |
| FY2015 | Dec 31, 2015 | $673.26K | +369.4% |
| FY2014 | Dec 31, 2014 | $143.42K | +359.1% |
| FY2013 | Dec 31, 2013 | $31.24K | -76.8% |
| FY2012 | Dec 31, 2012 | $134.79K | +26.6% |
| FY2011 | Dec 31, 2011 | $106.44K | -48.7% |
| FY2010 | Dec 31, 2010 | $207.62K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $33.63M | +5.2% |
| Q1 FY2026 | Mar 31, 2026 | $27.93M | -4.3% |
| Q4 FY2025 | Dec 31, 2025 | $30.08M | -1.6% |
| Q3 FY2025 | Sep 30, 2025 | $31.49M | +4.8% |
| Q2 FY2025 | Jun 30, 2025 | $31.97M | +9.1% |
| Q1 FY2025 | Mar 31, 2025 | $29.19M | -8.5% |
| Q4 FY2024 | Dec 31, 2024 | $30.56M | +11.8% |
| Q3 FY2024 | Sep 30, 2024 | $30.06M | +8.7% |
| Q2 FY2024 | Jun 30, 2024 | $29.30M | +3.1% |
| Q1 FY2024 | Mar 31, 2024 | $31.90M | +18.2% |
| Q4 FY2023 | Dec 31, 2023 | $27.35M | -6.5% |
| Q3 FY2023 | Sep 30, 2023 | $27.65M | -32.3% |
| Q2 FY2023 | Jun 30, 2023 | $28.41M | -32.3% |
| Q1 FY2023 | Mar 31, 2023 | $26.99M | +101.3% |
| Q4 FY2022 | Dec 31, 2022 | $29.24M | +1227.5% |
| Q3 FY2022 | Sep 30, 2022 | $40.86M | +1533.3% |
| Q2 FY2022 | Jun 30, 2022 | $41.99M | +2210.9% |
| Q1 FY2022 | Mar 31, 2022 | $13.41M | +621.5% |
| Q4 FY2021 | Dec 31, 2021 | $2.20M | +110.7% |
| Q3 FY2021 | Sep 30, 2021 | $2.50M | +354.5% |
| Q2 FY2021 | Jun 30, 2021 | $1.82M | +1211.8% |
| Q1 FY2021 | Mar 31, 2021 | $1.86M | +2818.1% |
| Q4 FY2020 | Dec 31, 2020 | $1.05M | +965.3% |
| Q3 FY2020 | Sep 30, 2020 | $550.52K | +276.2% |
| Q2 FY2020 | Jun 30, 2020 | $138.52K | +26.6% |
| Q1 FY2020 | Mar 31, 2020 | $63.69K | -94.9% |
| Q4 FY2019 | Dec 31, 2019 | $98.14K | -91.4% |
| Q3 FY2019 | Sep 30, 2019 | $146.34K | -86.7% |
| Q2 FY2019 | Jun 30, 2019 | $109.39K | -90.7% |
| Q1 FY2019 | Mar 31, 2019 | $1.25M | +24.4% |
| Q4 FY2018 | Dec 31, 2018 | $1.15M | +345.3% |
| Q3 FY2018 | Sep 30, 2018 | $1.10M | +331.4% |
| Q2 FY2018 | Jun 30, 2018 | $1.17M | +612.1% |
| Q1 FY2018 | Mar 31, 2018 | $1.00M | +4181.8% |
| Q4 FY2017 | Dec 31, 2017 | $257.49K | +299.8% |
| Q3 FY2017 | Sep 30, 2017 | $256.00K | -57.3% |
| Q2 FY2017 | Jun 30, 2017 | $164.34K | – |
| Q1 FY2017 | Mar 31, 2017 | $23.41K | – |
| Q4 FY2016 | Dec 31, 2016 | $64.40K | – |
| Q3 FY2016 | Sep 30, 2016 | $599.32K | – |